{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:37:20Z","timestamp":1773873440300,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"WHO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.biologicals.2018.11.004","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T16:30:45Z","timestamp":1543336245000},"page":"34-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation of two WHO First International Standards for Vi polysaccharide from Citrobacter freundii and Salmonella enterica subspecies enterica serovar Typhi"],"prefix":"10.1016","volume":"57","author":[{"given":"Fang","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Swann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rigsby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd","family":"Rijpkema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay","family":"Lockyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair","family":"Logan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bolgiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2018.11.004_bib1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0140-6736(00)44360-6","article-title":"A new antigen of B. typhosus. Its relation to virulence and to active and passive immunisation","volume":"227","author":"Felix","year":"1934","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2018.11.004_bib2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/infdis\/150.3.436","article-title":"Re-examination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi","volume":"150","author":"Robbins","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2018.11.004_bib3","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1128\/IAI.57.10.3159-3164.1989","article-title":"Characterization of the Salmonella paratyphi C vi polysaccharide","volume":"57","author":"Daniels","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2018.11.004_bib4","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM200310023491423","article-title":"Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children","volume":"349","author":"Lanh","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2018.11.004_bib5","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five- year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2018.11.004_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.62.10.4440-4444.1994","article-title":"Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines","volume":"62","author":"Szu","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2018.11.004_bib7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.biologicals.2018.11.004_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2018.11.004_bib9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/21645515.2015.1117715","article-title":"Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph\u2122) in Indian children: school based cluster randomized study","volume":"12","author":"Mitra","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2018.11.004_bib10","first-page":"101","article-title":"Guidelines on the quality, safety and efficacy of typhoid conjugate vaccines","volume":"987","author":"WHO","year":"2014","journal-title":"WHO Tech Rep Series"},{"key":"10.1016\/j.biologicals.2018.11.004_bib11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0008-6215(00)82210-7","article-title":"Strukturaufkl\u00e4rung des vi-antigens aus Citrobacter freundii (E. coli) 5396\/38","volume":"3","author":"Heyns","year":"1967","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.biologicals.2018.11.004_bib12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4049\/jimmunol.83.6.680","article-title":"The VI antigens of the Enterobacteriaceae. I. Purification and chemical properties","volume":"83","author":"Baker","year":"1959","journal-title":"J Immunol"},{"key":"10.1016\/j.biologicals.2018.11.004_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.biologicals.2018.11.004_bib14","first-page":"81","article-title":"Proposed First WHO international standards for Vi polysaccharide","volume":"999","author":"WHO","year":"2016","journal-title":"WHO Tech Rep Series"},{"key":"10.1016\/j.biologicals.2018.11.004_bib15","first-page":"1","article-title":"Recommendations for the preparation, characterization and establishment of international and other biological reference standards (revised 2004). 55th Meeting of the WHO Expert Committee on Biological Standardization, 15 to 18 November 2004","volume":"932","author":"WHO","year":"2006","journal-title":"WHO Tech Rep Ser"},{"key":"10.1016\/j.biologicals.2018.11.004_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.biologicals.2007.01.003","article-title":"Evaluation of the saccharide content and stability of the first WHO International Standard for Haemophilus influenzae b capsular polysaccharide","volume":"35","author":"Mawas","year":"2007","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2018.11.004_bib17","author":"Mawas"},{"key":"10.1016\/j.biologicals.2018.11.004_bib18","author":"Vipond"},{"key":"10.1016\/j.biologicals.2018.11.004_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.biologicals.2012.03.003","article-title":"Evaluation of a candidate international standard for meningococcal group C polysaccharide","volume":"40","author":"Vipond","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2018.11.004_bib20","author":"Vipond"},{"key":"10.1016\/j.biologicals.2018.11.004_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biologicals.2017.03.001","article-title":"Bolgiano B and the MenA\/MenX IS working group. Evaluation of candidate international standards for meningococcal serogroup A and X polysaccharide","volume":"47","author":"Vipond","year":"2017","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2018.11.004_bib22","author":"Bureau International des Poids"},{"key":"10.1016\/j.biologicals.2018.11.004_bib23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jpba.2005.01.043","article-title":"Validation of quantitative NMR","volume":"38","author":"Malz","year":"2005","journal-title":"J Pharmaceut Biomed Anal"},{"key":"10.1016\/j.biologicals.2018.11.004_bib24","first-page":"189","article-title":"Characterization of carbohydrate vaccines by NMR spectroscopy","volume":"vol. 1331","author":"Berti","year":"2015"},{"key":"10.1016\/j.biologicals.2018.11.004_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/biol.1999.0238","article-title":"Use and validation of an NMR test for the identity and O-acetyl content of the Salmonella typhi Vi capsular polysaccharide vaccine","volume":"28","author":"Lemerciner","year":"2000","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2018.11.004_bib26","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1016\/S0264-410X(99)00092-4","article-title":"Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines","volume":"17","author":"Ravenscroft","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2018.11.004_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9258(18)56740-5","article-title":"The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application","volume":"180","author":"Hestrin","year":"1949","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2018.11.004_bib28","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2010.11.022","article-title":"Vi-CRM197 as a new conjugate vaccine against Salmonella Typhi","volume":"29","author":"Micoli","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2018.11.004_bib29","first-page":"317","volume":"1","author":"Walker","year":"1984","journal-title":"Rocket Immunoelectrophoresis. Methods Mol Biol."},{"key":"10.1016\/j.biologicals.2018.11.004_bib30","first-page":"113","article-title":"Characterization of multivalent pneumococcal conjugate vaccines","volume":"103","author":"Katkocin","year":"2000","journal-title":"Dev Biol"},{"key":"10.1016\/j.biologicals.2018.11.004_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/biol.2001.0320","article-title":"Quality control of polyvalent pneumococcal polysaccharide protein conjugate vaccines by nephelometry","volume":"30","author":"Lee","year":"2002","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2018.11.004_bib32","first-page":"70","article-title":"First WHO international standards for Citrobacter freundii and Salmonella Typhi Vi polysaccharides","volume":"1011","author":"WHO","year":"2018","journal-title":"WHO Tech Rep Series"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618302690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618302690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T15:52:04Z","timestamp":1694101924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105618302690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":32,"alternative-id":["S1045105618302690"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2018.11.004","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of two WHO First International Standards for Vi polysaccharide from Citrobacter freundii and Salmonella enterica subspecies enterica serovar Typhi","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2018.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}]}}